Latest Industry Insights

In this interview, Xiaobo Wang discusses some of the NovoCyte Opteon’s advanced spectral capabilities and how they help to address existing challenges in flow cytometry.

Jeffery Zonderman, senior vice-president at Bruker Applied MS, joined Technology Networks for an interview at this year's American Society for Mass Spectrometry event.

Learn from James Hallam, vice president of the Research, Development and Advanced Testing Business segment at Waters Corporation, about how technological advancements in mass spectrometry are powering new discoveries in omics research.

In bioanalysis, AI could alleviate preclinical and clinical bioanalytical data processing and analysis. Here, Mary Belfast from Teva Branded Pharmaceuticals, discusses some of the latest guidelines on AI implementation and validation in bioanalysis.

Dr. Sergio Pérez Rosal explains why, in his opinion, “hope is not lost” and the therapeutic potential of psychedelics for the treatment of psychiatric disorders could still be unlocked. But what happens next must be firmly rooted in science.

Technology Networks joined Tarun Anumol for a discussion about the major challenges facing PFAS testing at this year’s ASMS conference.

Technology Networks joined Agilent Technologies for a discussion about new advances in gas chromatography at this year’s ASMS conference.

Technology Networks joined Agilent Technologies for a discussion about the company’s latest product launches at this year’s ASMS conference.

Technology Networks recently spoke with Dr. Holly Lee and Dr. Craig Butt from SCIEX to learn more about the analytical challenges of detecting PFAS and SCIEX’s 7500+ system to aid developments in mass spectrometry.

We sat down with Dr. John Puglia, senior director of research and development at Thermo Fisher, to learn more about their new biobased films and other sustainability initiatives.